First announced in June 2024, the acquisition will expand plan options and opportunities for members of both plans.
Grand Rapids, Michigan — Priority Health's acquisition of Fort Wayne–based Physicians Health Plan of Northern Indiana (PHPNI) was completed on December 1, following an initial announcement in June. At that time, Gary Shearer, president and CEO of PHPNI, noted, “Joining Priority Health has great potential to offer additional resources and innovation to PHPNI customers and members. We expect this transaction will benefit the communities and businesses we serve.”
By coming together, Priority Health and PHPNI hope their respective members will be able to take advantage of plan offerings from the new partners. | Image Credit: © PHPNI
The new deal means that opportunities from both plans will now be available to all members, which encompass Priority's more than 1.3 million members and PHPNI's 52,000-plus members. This strategic move marks an expansion into Ohio and within Indiana for the 2 plans, which received financial advisory assistance from Cain Brothers and legal guidance from Faegre Drinker Biddle & Reath LLP (PHPNI) and Taft Stettinius & Hollister (Priority Health).
“With approvals complete, we will now be working over the next several months to develop opportunities for both companies to continue to grow and leverage each other’s strengths as we plan for future growth,” said Praveen Thadani, president and CEO of Priority Health.
Click here for more information.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More